Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Choosing the right lipid-regulating agent. A guide to selection

J A Farmer1, A M Gotto

  • 1Department of Medicine, Baylor College of Medicine, Houston, Texas, USA.

Drugs
|November 1, 1996
PubMed
Summary

Lipid-regulating drugs supplement lifestyle changes for abnormal blood lipid levels. Bile acid sequestrants and HMG-CoA reductase inhibitors lower LDL cholesterol, while nicotinic acid and fibric acid derivatives reduce triglycerides.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Plasma lipids and other cardiovascular risk factors in Costa Rican adolescents.

Revista panamericana de salud publica = Pan American journal of public health·2001
Same author

Therapeutic impact of statin therapy in patients with low HDL cholesterol.

Current atherosclerosis reports·2000
Same author

Effect of lovastatin on cardiovascular resource utilization and costs in the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS). AFCAPS/TexCAPS Research Group.

The American journal of cardiology·2000
Same author

Apolipoprotein E genotypes and response of plasma lipids and progression-regression of coronary atherosclerosis to lipid-lowering drug therapy.

Journal of the American College of Cardiology·2000
Same author

Risk reduction.

Circulation·2000
Same author

Case 1: a patient with elevated low-density lipoprotein cholesterol.

The American journal of cardiology·2000

Area of Science:

  • Pharmacology
  • Cardiovascular Medicine
  • Metabolic Disorders

Background:

  • Dietary and lifestyle modifications are primary interventions for dyslipidaemia.
  • When lifestyle changes are insufficient, pharmacological intervention is necessary to normalize blood lipid levels.
  • Optimizing treatment requires patient assessment, clear goal setting, and understanding drug mechanisms.

Purpose of the Study:

  • To review the role and mechanisms of lipid-regulating drugs in managing dyslipidaemia.
  • To highlight agents effective in lowering low-density lipoprotein (LDL) cholesterol and triglycerides.
  • To emphasize the importance of monitoring for adverse effects and drug interactions.

Main Methods:

  • Review of available lipid-regulating agents and their pharmacological actions.

Related Experiment Videos

  • Comparison of drug efficacy in lowering LDL cholesterol and triglycerides.
  • Discussion of safety profiles and monitoring requirements.

    • Main Results:

    • Bile acid sequestrants and HMG-CoA reductase inhibitors are potent LDL cholesterol-lowering agents.
    • Nicotinic acid and fibric acid derivatives demonstrate significant triglyceride-lowering effects.
    • Established safety profiles exist, but patient monitoring for adverse events is crucial.

    Conclusions:

    • Lipid-regulating drugs are effective adjuncts to lifestyle changes for managing dyslipidaemia.
    • Understanding drug mechanisms and individual patient needs optimizes therapeutic outcomes.
    • Careful monitoring ensures the safe and effective use of these medications.